Stelara 90 MG/ML syringeml

Ended Awarded Last action

Contract number
SPE2DR26FCPL4
Awardee
Awarding agency
Obligated
$199,010

Award facts

Contract value 100% obligated
$199,009.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $199,009.56 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, for Stelara 90 mg/ml syringes under a firm fixed-price arrangement, with completion by March 26, 2026.

DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a single-award indefinite delivery contract that authorizes DLA to issue delivery orders for pharmaceutical products to support military healthcare facilities worldwide. Place of performance is Park Ridge, IL.

Quick answers

Who was awarded contract SPE2DR26FCPL4?

SPE2DR26FCPL4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 5, 2026.

How much is contract SPE2DR26FCPL4 worth?

The government has obligated $199,010 on SPE2DR26FCPL4.

Is contract SPE2DR26FCPL4 an order under another contract?

Yes. SPE2DR26FCPL4 is a delivery order under SPE2DR25D9131, an indefinite delivery contract.

Was contract SPE2DR26FCPL4 competed?

The extent of competition for SPE2DR26FCPL4 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award